Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

Författare

  • Xiujuan Li
  • Narendra Padhan
  • Elisabet O Sjöström
  • Francis P Roche
  • Chiara Testini
  • Naoki Honkura
  • Miguel Sáinz-Jaspeado
  • Emma Gordon
  • Katie Bentley
  • Andrew Philippides
  • Vladimir Tolmachev
  • Elisabetta Dejana
  • Radu V Stan
  • Dietmar Vestweber
  • Kurt Ballmer-Hofer
  • Christer Betsholtz
  • Kristian Pietras
  • Leif Jansson
  • Lena Claesson-Welsh

Summary, in English

The specific role of VEGFA-induced permeability and vascular leakage in physiology and pathology has remained unclear. Here we show that VEGFA-induced vascular leakage depends on signalling initiated via the VEGFR2 phosphosite Y949, regulating dynamic c-Src and VE-cadherin phosphorylation. Abolished Y949 signalling in the mouse mutant Vegfr2(Y949F/Y949F) leads to VEGFA-resistant endothelial adherens junctions and a block in molecular extravasation. Vessels in Vegfr2(Y949F/Y949F) mice remain sensitive to inflammatory cytokines, and vascular morphology, blood pressure and flow parameters are normal. Tumour-bearing Vegfr2(Y949F/Y949F) mice display reduced vascular leakage and oedema, improved response to chemotherapy and, importantly, reduced metastatic spread. The inflammatory infiltration in the tumour micro-environment is unaffected. Blocking VEGFA-induced disassembly of endothelial junctions, thereby suppressing tumour oedema and metastatic spread, may be preferable to full vascular suppression in the treatment of certain cancer forms.

Avdelning/ar

Publiceringsår

2016-03-23

Språk

Engelska

Publikation/Tidskrift/Serie

Nature Communications

Volym

7

Dokumenttyp

Artikel i tidskrift

Förlag

Nature Publishing Group

Ämne

  • Cell and Molecular Biology

Status

Published

Forskningsgrupp

  • Experimental oncology

ISBN/ISSN/Övrigt

  • ISSN: 2041-1723